As the new data presented made clear, our field continues to witness great progress as outcomes in the treatment of rheumatic disease improve impressively, new drugs gain approval, and the number of rheumatologists around the world skyrockets. More than 16,000 people attended this year’s EULAR congress, coming from over 120 countries. EULAR is really an international meeting that is held in Europe, just as the ACR is really an international meeting held in the United States.
Having braved nature’s fury and man’s feats of engineering to arrive safely at EULAR, I will pause here. Next month’s column will discuss the science and pageantry of EULAR 2011.
Dr. Pisetsky is physician editor of The Rheumatologist and professor of medicine and immunology at Duke University Medical Center in Durham, N.C.